Speciality: Infectious diseases
Description:
A warm welcome to all the medical professionals in this interesting session on Omicron: What to know about this new COVID-19 variant? - By Dr. Preeti Parmar
Dr. Preeti Parmar provides a comprehensive overview of Omicron, a new COVID-19 variant that has become a significant concern globally. Identified first in South Africa in late 2021, Omicron is notable for its extensive
mutations in the spike protein, which impact the virus's transmissibility and immune evasion capabilities.
Omicron's high number of mutations has made it more transmissible than previous variants. Dr. Parmar explains that this has led to rapid increases in case numbers worldwide, even in populations with high vaccination rates. While early data suggests that Omicron may result in milder illness compared to the Delta variant, its enhanced spread poses substantial risks, especially to healthcare systems already burdened by the pandemic.
Vaccination remains a key strategy in combating Omicron. Dr. Parmar highlights that booster doses significantly improve protection against this variant, reinforcing the need for booster
campaigns. Moreover, she stresses the importance of maintaining other public health measures such as mask-wearing, social distancing, and regular testing to control its spread.
Therefore, get an overall knowledge of omicron: what to know about this new covid-19 variant? - By Dr. Preeti Parmar
See More Webinars @ Hidoc Webinars
1.
Physician Fights Insurer to Cover Her Baby's Brain Cancer Treatment
2.
A small rise in cancer was observed following the 1986 Chernobyl accident.
3.
First-Line Combination for Bladder Cancer Not Eligible for Cisplatin Just Misses Positive Outcome.
4.
New research uncovers link between cancer pathway and blood-retina barrier function
5.
Standardized criteria for amino acid PET imaging could improve diagnosis and treatment of brain metastases
1.
Bispecific Antibodies in DLBCL & Myeloma: Clinical Insights for Physicians
2.
Survivorship Planning Beyond Active Cancer Care
3.
Understanding Blood Dyscrasia: Symptoms, Causes and Treatment Options
4.
Integrated Models in Hematology for Specialists
5.
Matrix Metalloproteinases in Stroke: Broad vs. Selective Inhibition Strategies
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
5.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation